Search results
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 days agoAn expected three-and-a-half week trial before judge Mr Justice Meade started on Tuesday focusing on...
Shanghai to Subsidize Construction of Standard Essential Patent Pools
The National Law Review· 16 hours agoFourteen other funding measures are also available including up to 2 million RMB for foreign...
Patent Case Summaries | Week Ending April 12, 2024 | JD Supra
JD Supra· 7 days agoSalix timely sued, asserting that Norwich’s ANDA infringed the patents. Following a bench trial, the district court held that Norwich infringed patents ...
F. Jason Far-hadian
The National Law Review· 7 hours agoJason is an experienced intellectual property lawyer with a focus on counseling and representing national and international technology clients in all matters involving the procurement, protection ...
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
Reuters via AOL· 3 days agoThe U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals to revive patents...
JD Supra: Patent Poetry: Patent and Trademark Offices Publish Study on NFT IP Issues
JD Supra· 23 hours agoThe US Patent and Trademark Office (USPTO) and the Copyright Office have published the results of their joint study on non-fungible tokens (NFTs) and intellectual property ...
Abraham Kasdan
The National Law Review· 2 days agoAbe is a Partner in the firm’s Intellectual Property Practice Group. As a former research scientist with a Ph. D. in physics and more than 15 years of research and development (R & D) experience ...
Q1 2024 Impinj Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 hours agoOn the intellectual property front, in March, we successfully settled our patent dispute with NXP, including a multiyear litigation during which impinged ...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 2 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London ...
Moderna Investors Should Beware Patent-Dispute Fallout (NASDAQ:ABUS)
Seeking Alpha· 2 days agoModerna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.
